160 related articles for article (PubMed ID: 19837632)
1. Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction.
Contassot E; Preynat-Seauve O; French L; Huard B
Trends Immunol; 2009 Dec; 30(12):569-73. PubMed ID: 19837632
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
3. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.
Schildknecht A; Probst HC; McCoy KD; Miescher I; Brenner C; Leone DP; Suter U; Ohashi PS; van den Broek M
Eur J Immunol; 2009 Jun; 39(6):1505-15. PubMed ID: 19462379
[TBL] [Abstract][Full Text] [Related]
4. Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process.
Preynat-Seauve O; Contassot E; Schuler P; Piguet V; French LE; Huard B
Cancer Res; 2007 May; 67(10):5009-16. PubMed ID: 17510433
[TBL] [Abstract][Full Text] [Related]
5. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
Neuenhahn M; Busch DH
Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
[TBL] [Abstract][Full Text] [Related]
6. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes.
Bousso P; Robey E
Nat Immunol; 2003 Jun; 4(6):579-85. PubMed ID: 12730692
[TBL] [Abstract][Full Text] [Related]
8. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo.
Norbury CC; Malide D; Gibbs JS; Bennink JR; Yewdell JW
Nat Immunol; 2002 Mar; 3(3):265-71. PubMed ID: 11828323
[TBL] [Abstract][Full Text] [Related]
9. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.
Asano K; Nabeyama A; Miyake Y; Qiu CH; Kurita A; Tomura M; Kanagawa O; Fujii S; Tanaka M
Immunity; 2011 Jan; 34(1):85-95. PubMed ID: 21194983
[TBL] [Abstract][Full Text] [Related]
10. CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor.
McDonnell AM; Prosser AC; van Bruggen I; Robinson BW; Currie AJ
Eur J Immunol; 2010 Jun; 40(6):1617-27. PubMed ID: 20373290
[TBL] [Abstract][Full Text] [Related]
11. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
Lund AW; Duraes FV; Hirosue S; Raghavan VR; Nembrini C; Thomas SN; Issa A; Hugues S; Swartz MA
Cell Rep; 2012 Mar; 1(3):191-9. PubMed ID: 22832193
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell migration to peripheral lymph nodes.
Martín-Fontecha A; Lanzavecchia A; Sallusto F
Handb Exp Pharmacol; 2009; (188):31-49. PubMed ID: 19031020
[TBL] [Abstract][Full Text] [Related]
13. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen.
Bai XF; Gao JX; Liu J; Wen J; Zheng P; Liu Y
Cancer Res; 2001 Sep; 61(18):6860-7. PubMed ID: 11559562
[TBL] [Abstract][Full Text] [Related]
14. Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
Schuler P; Contassot E; Irla M; Hugues S; Preynat-Seauve O; Beermann F; Donda A; French LE; Huard B
Cancer Res; 2008 Oct; 68(20):8410-8. PubMed ID: 18922914
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease.
Avogadri F; Mittal D; Saccheri F; Sarrafiore M; Ciocca M; Larghi P; Orecchia R; Rescigno M
Eur J Immunol; 2008 Jul; 38(7):1937-47. PubMed ID: 18581324
[TBL] [Abstract][Full Text] [Related]
16. Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB.
Keech CL; Pang KC; McCluskey J; Chen W
Eur J Immunol; 2010 Feb; 40(2):330-8. PubMed ID: 19950171
[TBL] [Abstract][Full Text] [Related]
17. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
18. Monocytes as effector cells: activated Ly-6C(high) mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells.
Leirião P; del Fresno C; Ardavín C
Eur J Immunol; 2012 Aug; 42(8):2042-51. PubMed ID: 22585535
[TBL] [Abstract][Full Text] [Related]
19. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J
J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]